ICICI Bank today announce a commitment to contribute Rs 1,200 crore towards Tata Memorial Centre (TMC), a premier institution that runs cancer treatment and research centres across the country.
ICICI Bank will donate the money from its CSR funds to set up three new buildings spanning over a combine area of 7.5 lakh square feet and equip them with state-of-the-art machines at TMC’s centres at Navi Mumbai in Maharashtra, Mullanpur in Punjab and Visakhapatnam in Andhra Pradesh.
With the largest contribution from any institution to TMC, ICICI Foundation for Inclusive Growth (ICICI Foundation), the CSR arm of ICICI Bank, will implement the initiative, which is likely to be complete by 2027.
With modern equipment and specialise multidisciplinary teams, these new centres of excellence in oncology treatment will provide advance and evidence based therapies to nearly 25,000 new patients a year, doubling the present capacity and providing a significant boost to the country’s cancer treatment infrastructure.
ICICI Foundation has sign an agreement with TMC to express this commitment.
Mr. Sanjay Datta, President, ICICI Foundation and Dr. R. A. Badwe, Director, Tata Memorial Centre signed the agreement in the presence of Mr. Girish Chandra Chaturvedi, Chairman, ICICI Bank and Mr. Sandeep Batra, Executive Director, ICICI Bank.
Mr. Chaturvedi also inaugurate the ICICI MRI Facility today at Tata Memorial Hospital at Parel in Mumbai in the presence of Dr. Badwe and Mr. Batra.
This facility is equip with an advance MRI machine support by ICICI Foundation.
Mr. Girish Chandra Chaturvedi, Chairman, ICICI Bank, said :
Dr. R. A. Badwe, Director, Tata Memorial Centre, said :
The salient features of ICICI Bank’s commitment are:
ICICI Foundation will set up an ‘ICICI Radiation Oncology Block’ at TMC’s Advanced Centre for Treatment, Research & Education in Cancer (ACTREC) at Navi Mumbai, Maharashtra.
This block will be equip with state-of-the-artradiology facilities including CT scanner and MRT, new facility for outdoor patients, laboratories and radiotherapy facility for in-patients.
All these together under one roof will help reduce waiting time significantly for investigations and hence enhance the quality of treatment.
ICICI Foundation will set up two ‘ICICI Paediatric and Haematological Oncology Block’ at TMC’s Homi Bhabha Cancer Hospital and Research Centre at Mullanpur in Punjab and Visakhapatnam in Andhra Pradesh.
These centres will provide an array of advanced equipment and therapies, which are required to treat paediatric and haematological cancer.
The facilities will include intense chemotherapy, bone marrow transplantation, radiation therapy and newer immunotherapies like CAR-T cell, which are available only at super specialised centres.
For the convenience of in-patient care, the centres will also have dedicated beds, day care units, ICUs, MRI and CT – PET Scan facility as well as laboratories for advanced testing including genetics, which are critical for treating paediatric and haematological cancers.
These centres will also become regional referral centres in the entire southern and northern parts of the country.
About ICICI Bank
ICICI Bank Ltd (BSE: ICICIBANK, NSE: ICICIBANK and NYSE:IBN) is a leading private sector bank in India.
The Bank’s total assets stood at ₹ 15,84,207 crore at March 31, 2023.
About ICICI Foundation
ICICI Bank set up ICICI Foundation for Inclusive Growth in 2008 to enhance and expand its social development efforts.
ICICI Foundation operates in the areas of environment protection, livelihood and skill development for the underprivileged, affordable healthcare, and financial inclusion across the country.
Through its various initiatives, ICICI Foundation has positively impacted the lives of over 10.9 million beneficiaries as on March 31, 2023.